Camurus AB announced the appointment of Behshad Sheldon as President of Camurus Inc. and member of the company's executive management team, starting 1 April 2024. Behshad has been a member of it's Board of Directors since 2018, contributing to it' development as a successful and profitable, commercial-stage pharmaceutical company. Behshad brings more than 25 years of experience from leading positions within the international pharmaceutical industry, including as President & CEO of Braeburn Pharmaceuticals up to 2017, and from senior positions within Smithkline Beecham, Bristol-Myers Squibb and Otsuka Pharmaceuticals, where she led successful blockbuster brands such as Glucophage, Plavix, and Abilify.

Most recently Behshad was a Managing Director at Biotech Value Advisors where she supported biotech and pharmaceutical companies with pre-launch and commercialization efforts in the US.